COLGATE PALMOLIVE CO CL
COLGATE PALMOLIVE CO financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.4B | $20.1B | $19.5B | $18.0B | $17.4B | $16.5B | $15.7B | $15.5B | $15.5B | $15.2B |
| Gross profit | $12.3B | $12.2B | $11.3B | $10.2B | $10.4B | $10.0B | $9.3B | $9.2B | $9.3B | $9.1B |
| R&D expense | $366.0M | $355.0M | $343.0M | $320.0M | $307.0M | $290.0M | $281.0M | $277.0M | $285.0M | $289.0M |
| SG&A expense | $7.9B | $7.7B | $7.2B | $6.6B | $6.4B | $6.0B | $5.6B | $5.4B | $5.4B | $5.1B |
| Operating income | $3.3B | $4.3B | $4.0B | $2.9B | $3.3B | $3.9B | $3.6B | $3.7B | $3.7B | $4.0B |
| Income tax | $798.0M | $907.0M | $937.0M | $693.0M | $749.0M | $787.0M | $774.0M | $906.0M | $1.3B | $1.2B |
| Net income | $2.1B | $2.9B | $2.3B | $1.8B | $2.2B | $2.7B | $2.4B | $2.4B | $2.0B | $2.4B |
| EPS (diluted) | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 |
| Operating cash flow | $4.2B | $4.1B | $3.7B | $2.6B | $3.3B | $3.7B | $3.1B | $3.1B | $3.1B | $3.1B |
| Free cash flow | — | — | — | $1.9B | $2.8B | $3.3B | $2.8B | $2.6B | $2.5B | $2.5B |
| Cash & equivalents | $1.3B | $1.1B | $966.0M | $775.0M | $832.0M | $888.0M | $883.0M | $726.0M | $1.5B | $1.3B |
| Inventory | $2.0B | $2.0B | $1.9B | $2.1B | $1.7B | $1.7B | $1.4B | $1.2B | $1.2B | $1.2B |
| Total assets | $16.3B | $16.0B | $16.4B | $15.7B | $15.0B | $15.9B | $15.0B | $12.2B | $12.7B | $12.1B |
| Total liabilities | $16.0B | $15.5B | $15.4B | $14.9B | $14.1B | $14.8B | $14.5B | $12.0B | $12.4B | $12.1B |
| Shareholders' equity | $365.0M | $544.0M | $957.0M | $806.0M | $971.0M | $1.1B | $558.0M | $197.0M | $243.0M | -$243.0M |
Growth · year-over-year · Revenue CAGR 3.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +1.4% | +3.3% | +8.3% | +3.1% | +5.8% | +5.0% | +1.0% | +0.6% | +1.7% | -5.2% |
| Net income growth | -26.2% | +25.6% | +28.9% | -17.6% | -19.6% | +13.9% | -1.4% | +18.6% | -17.1% | +76.4% |
| EPS growth | -25.1% | +26.7% | +30.0% | -16.5% | -18.8% | +14.2% | +0.0% | +20.6% | -16.2% | +78.9% |
| Free cash flow growth | — | — | — | -32.6% | -16.7% | +18.3% | +6.8% | +4.8% | -1.8% | +12.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.